查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863166

全球超音波設備市場：洞察、競爭格局及至2032年預測

Ultrasound Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

超音波設備市場摘要

  • 全球超音波設備市場預計將從 2024 年的 93.1506 億美元成長到 2032 年的 130.5468 億美元，反映出強勁且持續的成長。
  • 全球超音波設備市場在 2025 年至 2032 年的預測期內將以 4.38% 的複合年成長率成長。
  • 全球超音波設備市場正蓬勃發展，這主要得益於人們對早期精準診斷的需求不斷成長、微創手術應用日益廣泛，以及3D/4D成像、人工智慧和可攜式系統技術的進步。此外，超音波設備在成本效益、安全性以及包括產科、循環系統和慢性病管理在內的廣泛應用，也進一步推動了其普及。新興市場醫療服務可近性的提高也為市場成長提供了助力。
  • 超音波設備市場的主要企業包括：GE醫療、西門子醫療、佳能醫療系統株式會社、深圳邁瑞生物醫療電子股份有限公司、日立有限公司、BPL醫療技術公司、SonoScape醫療公司、Butterfly Network公司、Carestream Health公司、Clarius Mobile Health公司、Trivitron Healthcare公司、Chison Medical Imaging 公司、Carestream Health公司、Clarius Mobile Health、Trivitron Healthcare公司、Chison Medical Imaging Co.L. Imaging公司。
  • 北美超音波設備市場持續成長，這主要得益於其完善的醫療基礎設施、先進成像技術的廣泛應用以及主要醫療設備製造商的強大實力。心血管疾病、癌症和肝病等慢性疾病的日益普遍，推動了對早期精準影像診斷的需求。此外，該地區還受益於有利的醫療保險政策、不斷上漲的醫療成本以及日益增強的預防保健意識。人工智慧超音波和可攜式床邊診斷系統等持續的產品創新，進一步推動了醫院和門診中心對超音波設備的應用。此外，人口老化以及超音波在婦科、心臟病學和急診護理等領域的日益普及，也推動了該市場的強勁成長。
  • 根據產品類型分類，超音波設備市場預計將以2D超音波設備為主，預計到 2024 年，2D超音波設備將佔最大的市場佔有率。

超音波設備市場成長要素

  • 慢性病盛行率上升推動超音波設備市場快速擴張。心血管疾病、癌症和肝損傷等慢性病盛行率的上升是推動市場成長的主要因素。由於其非侵入性和即時性，超音波已成為診斷、監測和管理這些疾病的重要工具。
  • 人們越來越偏好非侵入性、安全的診斷方法：與X光和電腦斷層掃描不同，超音波不使用電離輻射，因此更安全，尤其適用於孕婦、兒童等敏感人群，或用於慢性病監測。這種固有的安全性使其成為首選的影像學檢查方式。
  • 技術進步：這可以說是最重要的促進因素。技術創新使超音波系統更強大、用途更廣泛、更易於使用。
  • 小型化和便攜性：小型攜帶式超音波設備（通常稱為床邊超音波，POCUS）的開發是一項突破。這些設備，其中一些可以連接到智慧型手機或平板電腦，能夠在患者床邊、急診室、救護車上以及偏遠和農村地區進行即時成像，大大擴展了超音波檢查的覆蓋範圍。
  • 人工智慧（AI）整合：人工智慧和機器學習演算法正被整合到超音波系統中，以提高影像品質、實現測量自動化並輔助診斷。人工智慧可以幫助經驗不足的使用者獲得高品質影像，並標記潛在的異常情況以進行進一步檢查，從而提高診斷的準確性和效率。
  • 影像處理：高解析度 3D 和即時 4D 成像、彈性成像（測量組織硬度以檢測腫瘤和肝纖維化）以及造影超音波(CEUS) 等成像技術的進步，提供了更詳細、更準確的診斷資訊。
  • 無線連接和遠端超音波：無線換能器和雲端基礎的平台可以即時傳輸和共用影像，用於遠端會診和即時指導。

超音波設備市場報告區隔

本超音波設備市場報告全面概​​述了全球超音波設備市場，重點分析了關鍵趨勢、成長促進因素、挑戰和機會。報告按產品類型、設備顯示、便攜性、應用、最終用戶和地區進行了詳細的市場區隔。報告深入分析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。透過對產業領導者及其最新產品開發的詳細介紹，本報告為企業提供了識別市場潛力、制定策略規劃以及把握快速成長的超音波設備市場新機會所需的重要數據。

超音波設備是一種醫學影像工具，它利用高頻聲波即時產生人體內部影像。與X光不同，它不使用電離輻射，因此可以安全、非侵入性地觀察軟組織和器官，例如心臟、肝臟、腎臟和胎兒。

全球超音波設備市場正因慢性病盛行率上升、對早期精準診斷的需求不斷成長以及微創手術的日益普及而蓬勃發展。超音波技術的進步，例如3D/4D成像、人工智慧整合和攜帶式手持系統，進一步推動了其在醫院、診斷中心和照護現場環境中的應用。人們對孕產婦保健意識的提高以及人口老化也推動了產科和循環系統對超音波的需求。此外，與其他影像學檢查方式相比，超音波具有成本效益高、安全且無輻射等優點，因此成為更受歡迎的診斷工具。新興市場醫療基礎設施的不斷改進以及政府為提升診斷影像服務可近性而推出的利好政策，也進一步促進了市場成長。

全球超音波設備市場正因對早期精準診斷的需求不斷成長、微創手術應用日益廣泛以及3D/4D成像、人工智慧和可攜式系統的進步而持續擴張。這項擴張的根本推動力在於技術創新、全球人口老化以及慢性病負擔日益加重等因素的共同作用。例如，世界衛生組織（WHO）的數據顯示，2019年慢性病約佔全球整體所有死亡人數的74%，較2010年的67%顯著上升。這一令人擔憂的趨勢，加上慢性病患病率的不斷攀升——僅心血管疾病就影響著全球超過5.23億人——以及預計到2040年癌症病例將成長近50%，共同造就了對安全、非侵入性診斷成像技術的持續需求。

作為一種無輻射的檢查方式，超音波越來越受到人們的青睞，用於常規檢查、早期篩檢和長期監測這些疾病，直接應對這項公共衛生挑戰。

此外，全球老年人口不斷成長，其中相當一部分60歲及以上人群患有至少一種慢性疾病，這是推動需求成長的主要人口因素。 2019年，60歲及以上人口數量約為10億，預計到2030年將達到約14億，到2050年將達到約21億，這將增加對篩檢和診斷的需求。

市場成長也得益於技術的微型化，促使攜帶式和手持式超音波設備迅速普及。這使得超音波從醫院的固定工具轉變為功能多樣的床邊診斷解決方案，普及了診斷影像服務。智慧型手機的普及為這些小型裝置創造了龐大的用戶群體，全球智慧型手機用戶超過72億，其中許多裝置可以直接連接到智慧型手機進行即時影像顯示。

人工智慧和機器學習的融合進一步放大了這一效應。人工智慧系統能夠自動最佳化影像品質、進行測量並輔助診斷，使超音波更容易被未經訓練的專業人員使用。開發中國家，特別是亞太地區的發展中國家，不斷增加醫療保健支出和基礎設施投資，對經濟高效的診斷解決方案的需求預計將持續成長，從而確保全球市場的擴張。

這些流行病學、人口統計和技術趨勢正在加速醫院、診所和社區醫療保健機構採用診斷性超音波，從而支持強勁的市場成長。

儘管超音波設備市場成長強勁，但仍面臨許多阻礙與課題，主要原因在於高成本和熟練專業人員的短缺。先進系統所需的初始投資高達數萬至數十萬美元，這對開發中國家的小型診所和醫療機構而言仍然是一大障礙。持續的維護和保養成本加劇了這一經濟負擔，常常迫使醫療機構選擇價格更低的翻新產品或推遲關鍵的技術升級。第二個同樣重要的挑戰是全球訓練有素的超音波和放射科醫師的短缺。超音波設備的有效性高度依賴操作者的技能，即使配備最先進的設備，合格人員的短缺也可能導致診斷錯誤。超音波的需求成長速度超過了供應速度，導致現有職位與新畢業生人數之間存在巨大差距。這種短缺導致患者等待時間過長，給現有專業人員帶來巨大壓力，並增加了職業倦怠的風險。此外，該市場受到包括美國FDA和歐盟在內的監管機構的嚴格監管，這可能會延遲產品上市並增加製造商的成本。最後，該市場的寡占性質，即由少數幾家大型企業主導，會造成激烈的競爭和價格壓力，限制規模較小、具有創新精神的企業進入市場並取得成功的能力。

超音波設備市場區隔分析超音波診斷

設備市場按產品類型、設備展示、便攜性、應用和地區分類

超音波設備市場區域分析

北美超音波設備市場趨勢

以美國主導的北美地區，預計2024年將佔全球超音波設備市場35%的佔有率。北美是全球超音波市場的主要成長引擎，這主要得益於高昂的醫療成本、床邊超音波（POCUS）的快速普及以及慢性病負擔沉重，這些因素共同推動了對診斷成像和監測的需求。預計到2024年，北美將佔全球POCUS市場約三分之一的佔有率，反映出急診室、基層醫療和門診等場所對床邊照護現場的廣泛應用。

該地區的流行病學特徵正在推動需求：僅在美國，2023年死於心臟病的人數就將達到約919,032人，這將維持較高的心臟影像和多普勒檢查使用率。人口趨勢也是關鍵因素：預計到2024年，美國65歲以上人口將達到6,120萬，這將增加對篩檢、慢性病追蹤和老年影像檢查的需求。

技術進步和人工智慧正在加速普及，製造商們推出了功能更強大的固定式和即時檢測系統，這些系統配備了人工智慧工作流程工具，例如GE醫療的新型Vivid Pioneer心血管超音波（已獲得CE/FDA 510(k)認證）和飛利浦最近推出的Flash 5100即時檢測系統，所有這些系統的目標床旁成像，更準確的醫院吞吐量提高的醫院吞吐量。

最後，治療性超音波的監管核准不斷增加，以及對遠端超音波和智慧型手機連接探頭的投資，正在擴大臨床應用案例（從常規產前掃描到緊急心臟分診），從而支持北美對市場成長的重大貢獻。

歐洲超音波設備市場趨勢

歐洲超音波設備市場在全球佔領先地位，市場佔有率顯著，這主要得益於先進的醫療基礎設施和對高效診斷工具的旺盛需求。其中一個最顯著的趨勢是可攜式手持超音波設備的日益普及，其在急診、基層醫療診所甚至居家照護等照護現場的應用也日益廣泛。這直接響應了人們對更快、更便捷的診斷的需求，而遠端醫療的興起進一步推動了這一趨勢。此外，歐洲人口老化及其導致的心血管疾病和癌症等慢性病發病率上升也對市場產生了顯著影響。超音波的非侵入性和即時監測功能使其成為管理這些慢性疾病的理想工具。

此外，歐洲醫療保健系統正積極擁抱科技創新。人工智慧 (AI) 的應用已成為一種強勁的趨勢，旨在提升影像品質、實現測量自動化並提高診斷準確性，有助於緩解熟練超音波醫師短缺的挑戰。儘管診斷超音波仍然是最大的區隔市場，但治療性超音波市場，尤其是超音波高強度聚焦超音波(HIFU)，已成為一個關鍵的成長領域，這主要得益於人們對非侵入性治療方案日益成長的關注。儘管成長強勁，但該市場仍面臨諸多挑戰，例如歐盟醫療設備法規 (MDR) 等嚴格的法律規範，以及來自價格較親民的中國供應商（尤其是在價格分佈市場）帶來的價格下行壓力。

亞太地區超音波設備市場趨勢

亞太地區超音波設備市場預計將成為全球成長最快的區域市場，中國和日本將引領這一市場成長，其促進因素包括人口成長和老化、經濟快速發展以及醫療保健成本上升等獨特因素。

該地區的醫療保健狀況的特徵是慢性病和非傳染性疾病（如心血管疾病和癌症）的盛行率很高。

此外，政府為改善都市區地區的醫療基礎設施和可近性所做的努力也發揮了關鍵作用，包括促進醫療設備的國內生產，尤其是在中國和印度，這促成了經濟實惠的超音波系統的生產。

儘管GE醫療和西門子醫療等老牌廠商佔著強大的市場地位，但邁瑞醫療和佳能醫療系統等以創新和價格分佈競爭力著稱的區域性主要廠商也在積極塑造著市場格局。此外，該地區多元化的醫療基礎設施和分散的人口分佈也促使可攜式和手持式超音波設備迅速普及，這些設備非常適合滿足照護現場診斷需求。

這些公司總合佔最大的市場佔有率，並引領產業趨勢。

  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Canon Medical Systems Corporation
  • Samsung Healthcare
  • FUJIFILM Holdings Corporation
  • Esaote SpA
  • Hologic, Inc.
  • Hitachi, Ltd
  • BPL Medical Technologies
  • SonoScape Medical Corporation
  • Butterfly Network, Inc.
  • Carestream Health
  • Clarius Mobile Health
  • Trivitron Healthcare
  • Chison Medical Imaging Co., Ltd.
  • Teratech Corporation
  • Wuhan Zoncare Bio-medical Electronics Co., Ltd.
  • SuperSonic Imagine
  • DMS Imaging
  • 其他

超音波設備市場的競爭格局瞬息萬變，市場集中度中等至較高。該市場由幾家大型、成熟的跨國公司主導，通常被稱為「四大巨頭」：通用電氣醫療集團（GE Healthcare）、皇家飛利浦公司（Koninklijke Philips NV）、西門子醫療（Siemens Healthineers）和佳能醫療系統公司（Canon Medical Systems Corporation）。這些公司憑藉著強大的品牌知名度、廣泛的全球分銷網路以及雄厚的研發投入，保持著市場主導地位。例如，通用電氣醫療集團（GE Healthcare）憑藉其在女性健康領域的領先地位，特別是其Voluson系列產品，估計佔了相當大的全球市場佔有率。

然而，這種競爭動態正受到新一波創新企業的挑戰。邁瑞醫療國際有限公司和三星麥迪遜等公司正透過提供兼具先進技術和極具競爭力的價格的產品，迅速擴大市場佔有率，尤其是在新興市場。此外，富士膠片Sonosite和Butterfly Network等專業製造商的崛起，正透過專注於攜帶式手持超音波設備，直接與傳統的推車式系統展開競爭，重塑市場格局。這加劇了競爭，並推動了一場技術創新競賽，迫使所有企業整合人工智慧、增強型影像處理和雲端連接等最尖端科技，以實現產品差異化並鞏固市場地位。

  • 2025 年 8 月，Esaote 的緊湊型平台 MyLab™ A50 和 MyLab™ A70 獲得 FDA 批准，作為具有先進影像處理和人工智慧功能的電池供電可攜式系統進入美國。
  • 2025 年 8 月，飛利浦宣佈在全球推出 Flash 5100 POC超音波系統，照護現場設備。
  • 2025 年 6 月，Exo 擴展了其手持式 Exo Iris® 的臨床功能，獲得了 FDA 510(k) 許可，可在設備上使用 AI 來檢測胸腔積液和實變，從而推進了 AI 賦能的 POCUS 診斷。
  • 2025 年 5 月，Exo Imaging 和三星麥迪遜宣佈建立策略合作夥伴關係，包括三星的投資，共同開發下一代超音波平台。
  • 2025 年 4 月，Exo 在其 Exo Iris®（已獲 FDA已經過核准）中增加了即時全局縱向應變 (GLS) 分析，使其成為第一款可在床邊進行心臟評估的裝置端 GLS 手持裝置。
  • 2025 年 4 月，飛利浦推出了 EPIQ Elite（以及相關的 Affiniti 平台）的 Elevate AI 平台升級，引入了自動影像最佳化和工作流程工具，以加快檢查速度並提高診斷一致性。
  • 2025 年 1 月，三星麥迪遜在美國推出了高階婦產科系統 HERA/Z20（在 SMFM 2025 上首次亮相）。
  • 2025 年 1 月，Hologic 以 3.5 億美元的價格完成了對 Gynesonics 的收購，Gynesonics 是 Sonata 系統（超音波導引系統）的開發商。

超音波設備市場區隔

  • 按產品類型分類的超音波設備市場趨勢
  • 2D
  • 3D/4D
  • 多普勒
  • 高強度聚焦超音波（HIFU）
  • 超音波設備顯示器曝光
  • 彩色超音波
  • 黑白超音波
  • 超音波設備便攜性
  • 固定式
  • 可攜式的
  • 按設備分類的超音波設備市場趨勢
  • 婦科
  • 循環系統
  • 泌尿系統
  • 整形外科
  • 其他
  • 按最終用戶分類的超音波設備市場趨勢
  • 醫院
  • 診斷中心
  • 診所
  • 門診手術中心
  • 其他
  • 各地區超音波設備市場趨勢
  • 北美超音波設備市場
  • 美國超音波設備市場
  • 加拿大超音波設備市場
  • 墨西哥超音波設備市場
  • 歐洲超音波設備市場
  • 英國超音波設備市場
  • 德國超音波設備市場
  • 法國超音波設備市場
  • 義大利超音波設備市場
  • 西班牙超音波設備市場
  • 其他歐洲超音波設備市場
  • 亞太超音波設備市場
  • 中國超音波設備市場
  • 日本超音波設備市場
  • 印度超音波設備市場
  • 澳洲超音波設備市場
  • 韓國超音波設備市場
  • 亞太地區其他超音波設備市場
  • 世界其他地區超音波設備市場
  • 南美洲超音波設備市場
  • 中東超音波設備市場
  • 非洲超音波設備市場

利用人工智慧進行影響分析

人工智慧 (AI) 的融合正在為超音波設備市場帶來變革性影響，從根本上重塑其功能並擴大其應用範圍。 AI 驅動的創新透過自動化耗時且依賴操作人員的任務，有效應對了長期存在的挑戰，顯著提升了工作流程的效率和準確性。例如，AI 演算法可以自動擷取和分析影像，使臨床醫生能夠專注於與患者的互動，並縮短檢查時間。

此外，人工智慧可以作為強大的診斷輔助工具，透過檢測細微異常和輔助病灶分類，提高診斷準確率並降低人為錯誤風險。然而，人工智慧最大的影響或許在於其對超音波檢查普及化的推動作用。人工智慧引導系統能夠提供使用者即時、逐步的回饋，讓經驗不足的醫護人員也能進行高品質的診斷掃描。這正是照護現場超音波（POCUS）市場爆炸性成長的關鍵因素，使其應用範圍不斷擴大，涵蓋診所、偏遠地區和急診環境。儘管面臨高成本和需要大量高品質資料集來訓練人工智慧模型等挑戰，但超音波技術的未來與人工智慧密不可分，人工智慧將持續提升其效用，並重新定義其在全球醫療保健領域的角色。

美國關稅對超音波設備市場的影響分析

對來自美國，尤其是來自中國和歐盟的醫療設備及零件徵收關稅，對全球超音波設備市場構成重大且多方面的挑戰。這些關稅可能大幅增加進口成本，直接擠壓製造商的利潤空間，或迫使其將這些增加的成本轉嫁給醫療機構，最終轉嫁給患者，因為醫院和診所，尤其是規模較小的醫院和診所，可能難以購買資本密集型設備。

此外，關稅會擾亂既有的複雜全球供應鏈，迫使企業迅速尋找新的供應商或考慮外包生產以避免額外成本。這會導致供不應求、物流延誤、營運成本增加和市場不穩定。雖然關稅旨在鼓勵國內生產，從長遠來看減少對海外供應商的依賴，但由於企業優先考慮成本控制而非新產品開發，關稅也可能導致研發投入減少，並扼殺創新。此外，受影響國家可能採取報復性關稅措施，進一步損害美國醫療設備出口，使競爭格局更加複雜。

  • 成本管理：了解關稅環境可以讓客戶預測成本上漲，並據此調整定價策略，確保盈利。
  • 供應鏈最佳化：可以確定替代採購方案，實現供應鏈多元化，以減少對高關稅地區的依賴，並提高韌性。
  • 監管導航：在不斷變化的法規環境中，專家指導可協助您保持合規並避免潛在的法律挑戰。
  • 策略規劃洞察關稅的影響使客戶能夠就製造地、夥伴關係和打入市場策略做出明智的決策。

目錄

第1章超音波設備市場報告概述

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章超音波設備市場摘要整理

  • 市場概覽

第3章：超音波設備

  • 市場促進因素
    • 慢性病盛行率上升
    • 人們對非侵入性和更安全的診斷方法越來越感興趣
    • 技術進步
    • 對照護現場（POCUS）的需求不斷成長
    • 拓展至超音波
  • 市場阻礙與課題
    • 超音波系統高成本
    • 嚴格的規章制度和報銷政策
    • 可攜式和手持式超音波設備面臨的挑戰
  • 市場機遇
    • 人工智慧（AI）與機器學習（ML）的融合

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章超音波設備市場：波特五力分析

第7章超音波設備市場評估

  • 依產品類型
    • 2D
    • 3D/4D
    • 多普勒
    • 高強度聚焦超音波（HIFU）
  • 透過設備顯示
    • 彩色超音波
    • 黑白超音波
  • 透過便攜性
    • 固定式
    • 可攜式的
  • 透過使用
    • 婦科
    • 心臟病學
    • 泌尿系統
    • 整形外科
    • 其他
  • 最終用戶
    • 醫院
    • 診斷中心
    • 診所
    • 門診手術中心
  • 地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

第10章超音波設備市場 公司及產品概況

  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Canon Medical Systems Corporation
  • Samsung Healthcare
  • FUJIFILM Holdings Corporation
  • Esaote SpA
  • Hologic, Inc.
  • Hitachi, Ltd
  • BPL Medical Technologies
  • SonoScape Medical Corporation
  • Butterfly Network, Inc.
  • Carestream Health
  • Clarius Mobile Health
  • Trivitron Healthcare
  • Chison Medical Imaging Co., Ltd.
  • Teratech Corporation
  • Wuhan Zoncare Bio-medical Electronics Co., Ltd.
  • SuperSonic Imagine
  • DMS Imaging

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0298

Ultrasound Devices Market Summary

  • The global ultrasound devices market is expected to increase from USD 9,315.06 million in 2024 to USD 13,054.68 million by 2032, reflecting strong and sustained growth.
  • The global ultrasound devices market is growing at a CAGR of 4.38% during the forecast period from 2025 to 2032.
  • The global ultrasound device market is growing due to rising demand for early and accurate diagnosis, increasing use in minimally invasive procedures, and advancements like 3D/4D imaging, AI, and portable systems. Its cost-effectiveness, safety, and wide applications in obstetrics, cardiology, and chronic disease management further boost adoption. Expanding healthcare access in emerging markets also supports growth.
  • The leading companies operating in the ultrasound devices market include GE HealthCare, Siemens Healthineers, Canon Medical Systems Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Canon Medical Systems Corporation, Samsung Healthcare, FUJIFILM Holdings Corporation, Esaote SpA, Hologic, Inc., Hitachi, Ltd, BPL Medical Technologies, SonoScape Medical Corporation, Butterfly Network, Inc., Carestream Health, Clarius Mobile Health, Trivitron Healthcare, Chison Medical Imaging Co., Ltd., Teratech Corporation, Wuhan Zoncare Bio-medical Electronics Co., Ltd., SuperSonic Imagine, DMS Imaging, and Others.
  • The North American ultrasound device market is dominating and growing due to its well-established healthcare infrastructure, high adoption of advanced imaging technologies, and strong presence of leading medical device manufacturers. The rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and liver diseases is driving demand for early and accurate diagnostic imaging. The region also benefits from favorable reimbursement policies, higher healthcare expenditure, and growing awareness of preventive healthcare. Continuous product innovations, such as AI-powered ultrasound and portable point-of-care systems, are further fueling adoption across hospitals and outpatient centers. In addition, the aging population and increasing use of ultrasound in women's health, cardiology, and emergency medicine are reinforcing the market's strong growth trajectory.
  • In the product type segment of the ultrasound devices market, the 2D category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Ultrasound Devices Market

  • Rising prevalence of chronic diseases leading to a surge in the ultrasound devices market: The increasing incidence of chronic diseases such as cardiovascular conditions, cancer, and liver disorders is a major market driver. Ultrasound is a vital tool for the diagnosis, monitoring, and management of these conditions due to its non-invasive and real-time nature.
  • Growing Preference for Non-Invasive and Safer Diagnostics: Ultrasound does not use ionizing radiation, unlike X-rays or CT scans. This makes it a safer option for repeated use, particularly for sensitive patients like pregnant women and children, as well as for monitoring chronic conditions. This inherent safety profile makes it a preferred imaging modality.
  • Advancement in Technology: This is arguably the most significant driver. Innovations have made ultrasound systems more powerful, versatile, and accessible:
  • Miniaturization and Portability: The development of compact, portable, and handheld ultrasound devices (often called Point-of-Care Ultrasound or POCUS) is a game-changer. These devices, some of which connect to smartphones or tablets, allow for real-time imaging at the patient's bedside, in emergency rooms, ambulances, and remote or rural areas, dramatically expanding the reach of ultrasound.
  • Integration of Artificial Intelligence (AI): AI and machine learning algorithms are being integrated into ultrasound systems to improve image quality, automate measurements, and assist in diagnosis. AI can help less experienced users acquire high-quality images and can flag potential abnormalities for further review, increasing diagnostic accuracy and efficiency.
  • Enhanced Imaging Capabilities: Advancements in imaging technology, such as high-resolution 3D and real-time 4D imaging, elastography (which measures tissue stiffness to detect tumors and liver fibrosis), and contrast-enhanced ultrasound (CEUS), provide more detailed and accurate diagnostic information.
  • Wireless Connectivity and Tele-Ultrasound: Wireless transducers and cloud-based platforms enable images to be transmitted and shared instantly for remote consultations and real-time guidance, which is crucial for telemedicine and remote healthcare delivery.

Ultrasound Devices Market Report Segmentation

This ultrasound devices market report offers a comprehensive overview of the global ultrasound devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (2D, 3D/4D, Doppler, and High-Intensity Focused Ultrasound (HIFU)), Device Display (Color Ultrasound, B/W Ultrasound), Portability (Stationary, Portable), Application (Gynecology, Cardiology, Urology, Orthopedic, and Others), End-Users (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing ultrasound devices market.

An ultrasound device is a medical imaging tool that uses high-frequency sound waves to create real-time images of the inside of the body. Unlike X-rays, it does not use ionizing radiation, making it a safe and non-invasive way to visualize soft tissues and organs, such as the heart, liver, kidneys, and an unborn baby.

The global ultrasound device market is growing due to the rising prevalence of chronic diseases, increasing demand for early and accurate diagnosis, and the expanding use of minimally invasive procedures. Advancements in ultrasound technology, such as 3D/4D imaging, AI integration, and portable handheld systems, are further driving adoption across hospitals, diagnostic centers, and point-of-care settings. Growing awareness of prenatal care and maternal health, coupled with the aging population, has also boosted demand for ultrasound in obstetrics and cardiology. Additionally, ultrasound is cost-effective, safe, and radiation-free compared to other imaging modalities, making it a preferred diagnostic tool. Expanding healthcare infrastructure in emerging markets and favorable government initiatives to enhance access to imaging services are further contributing to market growth.

What are the latest Ultrasound Devices Market Dynamics and Trends?

The global ultrasound device market is growing due to rising demand for early and accurate diagnosis, increasing use in minimally invasive procedures, and advancements like 3D/4D imaging, AI, and portable systems. This expansion is fundamentally driven by a confluence of technological innovation, an aging global population, and the escalating burden of chronic diseases. For instance, according to the World Health Organization, chronic diseases were responsible for approximately 74% of all deaths worldwide in 2019, a significant increase from 67% in 2010. This alarming trend, rising chronic disease prevalence, with cardiovascular disease alone impacting over 523 million people globally, and cancer cases projected to increase by nearly 50% by 2040, is creating sustained demand for safe and non-invasive imaging.

Ultrasound, being a radiation-free modality, is increasingly preferred for routine check-ups, early screening, and long-term monitoring of such conditions, directly addressing this public health challenge.

Furthermore, the global rise of the geriatric population, with a significant percentage of individuals aged 60 and above having at least one chronic condition, is a major demographic factor fueling demand. The number of people aged 60+ was about 1 billion in 2019 and is projected to reach ~1.4 billion by 2030 and 2.1 billion by 2050, increasing screening and diagnostic needs.

The market's growth is also being supercharged by the miniaturization of technology, leading to the proliferation of portable and handheld ultrasound devices. This has democratized access to imaging by transforming ultrasound from a static, hospital-based tool into a versatile, point-of-care solution. The widespread adoption of smartphones, with over 7.2 billion active subscriptions globally, has created a massive user base for these compact devices, as many can connect directly to a smartphone for a real-time display. This technical synergy with common consumer technology is enabling healthcare providers to perform quick and accurate diagnostics in a variety of settings, from a rural clinic to an ambulance, leading to faster treatment decisions and improved patient outcomes.

The integration of artificial intelligence and machine learning is further amplifying this effect, as AI-powered systems can automatically optimize image quality, perform measurements, and assist in diagnosis, making ultrasound even more accessible to professionals with limited training. As developing nations, particularly in the Asia-Pacific region, increase their healthcare spending and infrastructure investment, the demand for these affordable and effective diagnostic solutions will continue to accelerate, solidifying the market's global expansion.

Together, these epidemiologic, demographic, and technological trends are accelerating ultrasound adoption across hospitals, clinics, and community care, supporting robust market growth.

Despite the robust growth, the ultrasound devices market faces significant restraints and challenges, primarily stemming from high costs and the shortage of skilled professionals. The high initial investment required for advanced systems, which can range from tens to hundreds of thousands of dollars, remains a major barrier for smaller clinics and healthcare providers in developing countries. This financial hurdle is compounded by ongoing maintenance and servicing costs, often forcing institutions to opt for more affordable, refurbished equipment or to delay crucial technology upgrades. A second, equally critical challenge is the global shortage of trained sonographers and radiologists. The effectiveness of an ultrasound device is highly dependent on the operator's skill, and a lack of qualified personnel can lead to diagnostic errors, even with the most advanced machines. The demand for sonographers is increasing faster than the supply, with a significant gap between the number of open positions and the number of graduates entering the workforce. This shortage contributes to longer patient wait times and places a heavy workload on existing professionals, increasing the risk of burnout. Additionally, the market is subject to stringent regulatory hurdles from agencies like the U.S. FDA and the EU, which can delay product launches and increase costs for manufacturers. Finally, the market's oligopolistic nature, dominated by a few large companies, creates intense competition and price pressure, which can limit the ability of smaller, innovative players to enter and thrive in the market.

Ultrasound Devices Market Segment Analysis

Ultrasound Devices Market by Product Type Product Type (2D, 3D/4D, Doppler, and High-Intensity Focused Ultrasound (HIFU)), Device Display (Color Ultrasound, B/W Ultrasound), Portability (Stationary, Portable), Application (Gynecology, Cardiology, Urology, Orthopedic, and Others), End-Users (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Ultrasound Devices Market Regional Analysis

North America Ultrasound Devices Market Trends

North America, led by the U.S., accounted for a dominant ~35% share of the global ultrasound devices market in 2024. North America is a key growth engine for the global ultrasound market thanks to high healthcare spending, rapid POCUS adoption, and a large burden of chronic disease that drives demand for imaging and monitoring. North America held roughly one-third of the POCUS market in 2024, underscoring strong point-of-care uptake across ERs, primary care, and ambulatory settings.

The region's epidemiology amplifies demand; heart disease alone caused about 919,032 deaths in the U.S. in 2023, keeping cardiac imaging and Doppler use high. Demographics also matter: the U.S. population aged 65+ reached ~61.2 million in 2024, expanding screening, chronic-care follow-up, and geriatric imaging needs.

Technological advances and AI are accelerating uptake, and manufacturers are rolling out higher-performance stationary and POC systems with AI workflow tools, exemplified by GE HealthCare's new Vivid Pioneer cardiovascular ultrasound (CE/FDA 510(k) cleared) and Philips' recent Flash 5100 POC launch, both aimed at faster, more accurate bedside imaging and higher throughput in hospitals.

Finally, increasing regulatory approvals for therapeutic ultrasound and investments in tele-ultrasound and smartphone-connected probes are broadening clinical use cases (from routine prenatal scans to emergency cardiac triage), which together sustain North America's outsized contribution to market growth.

Europe Ultrasound Devices Market Trends

The European ultrasound devices market is a major global player, holding a significant share driven by its advanced healthcare infrastructure and a high demand for efficient diagnostic tools. One of the most prominent trends is the rising adoption of portable and handheld ultrasound devices, which are increasingly being used in point-of-care settings like emergency rooms, primary care clinics, and even home care. This is a direct response to the need for faster, more accessible diagnostics and is further fueled by the growth of telemedicine. The market is also heavily influenced by Europe's aging population and the corresponding increase in chronic diseases, such as cardiovascular conditions and cancer. Ultrasound's non-invasive nature and ability to provide real-time monitoring make it an ideal tool for managing these long-term conditions.

Furthermore, European healthcare systems are actively embracing technological innovation. There is a strong trend toward the integration of artificial intelligence (AI) to enhance image quality, automate measurements, and assist with diagnostic accuracy, which helps to mitigate the challenge of a shortage of skilled sonographers. While diagnostic ultrasound remains the largest segment, the therapeutic ultrasound market, particularly High-Intensity Focused Ultrasound (HIFU), is a key growth area, driven by a rising focus on non-invasive treatment options. Despite strong growth, the market faces challenges from stringent regulatory frameworks like the EU Medical Device Regulation (MDR) and pressure from price erosion, particularly in the lower-end segments due to the entry of more affordable Chinese vendors.

Asia-Pacific Ultrasound Devices Market Trends

The Asia-Pacific ultrasound devices market is poised to become the fastest-growing regional market globally, with China and Japan leading the way. This trend is driven by a unique set of factors, including a massive and aging population, rapid economic development, and increasing healthcare expenditure.

The region's healthcare landscape is characterized by a high prevalence of chronic and non-communicable diseases, such as cardiovascular diseases and cancer. This growing disease burden, coupled with increasing public awareness about early diagnosis, is creating a substantial demand for non-invasive and affordable diagnostic tools like ultrasound.

Furthermore, government initiatives aimed at improving healthcare infrastructure and accessibility in both urban and rural areas are playing a crucial role. This includes a push for domestic manufacturing of medical devices, which, particularly in China and India, is leading to the production of cost-effective ultrasound systems. This makes them more accessible to a wider patient base, especially in developing economies.

While established players like GE HealthCare and Siemens Healthineers have a strong presence, the market is also being shaped by key regional manufacturers like Mindray and Canon Medical Systems, who are known for their innovative and competitively priced products. The market is also seeing a rapid adoption of portable and handheld ultrasound devices, as they are ideal for addressing the need for point-of-care diagnostics in a region with diverse healthcare infrastructure and a large, spread-out population.

Who are the major players in the ultrasound devices market?

The following are the leading companies in the Ultrasound Devices market. These companies collectively hold the largest market share and dictate industry trends.

  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Canon Medical Systems Corporation
  • Samsung Healthcare
  • FUJIFILM Holdings Corporation
  • Esaote SpA
  • Hologic, Inc.
  • Hitachi, Ltd
  • BPL Medical Technologies
  • SonoScape Medical Corporation
  • Butterfly Network, Inc.
  • Carestream Health
  • Clarius Mobile Health
  • Trivitron Healthcare
  • Chison Medical Imaging Co., Ltd.
  • Teratech Corporation
  • Wuhan Zoncare Bio-medical Electronics Co., Ltd.
  • SuperSonic Imagine
  • DMS Imaging
  • Others

How is the competitive landscape shaping the ultrasound devices market?

The competitive landscape of the ultrasound devices market is highly dynamic and is characterized by a moderate to high level of market concentration. It is dominated by a few major, well-established multinational corporations, often referred to as the "Big Four": GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, and Canon Medical Systems Corporation. These companies leverage their strong brand recognition, extensive global distribution networks, and substantial R&D budgets to maintain a commanding presence. GE HealthCare, for example, is estimated to hold a significant global market share, particularly due to its leadership in women's health with the Voluson series.

However, this competitive dynamic is being challenged by a new wave of innovative players. Companies like Mindray Medical International Limited and Samsung Medison are rapidly gaining market share, particularly in emerging markets, by offering a blend of advanced technology and competitive pricing. Furthermore, the rise of specialized manufacturers like FUJIFILM Sonosite and Butterfly Network is reshaping the market through their focus on portable, handheld ultrasound devices, which directly compete with the traditional cart-based systems. This has intensified competition and is driving an innovation race, compelling all players to integrate cutting-edge technologies like AI, enhanced imaging, and cloud connectivity to differentiate their products and secure their market position.

Recent Developmental Activities in the Ultrasound Devices Market

  • In August 2025, Esaote's compact platforms MyLab(TM) A50 and MyLab(TM) A70 received FDA clearance, marking their U.S. entry as battery-operated, portable systems with advanced imaging and AI features.
  • In August 2025, Philips announced the global launch of the Flash 5100 POC ultrasound system, a point-of-care device built for fast bedside use in anesthesia, ICU, emergency, and MSK settings.
  • In June 2025, Exo expanded clinical capability on its handheld Exo Iris(R) by receiving FDA 510(k) clearance for on-device AI that detects pleural effusion and consolidation, advancing AI-enabled POCUS diagnostics.
  • In May 2025, Exo Imaging and Samsung Medison announced a strategic collaboration that includes equity investment from Samsung, aimed at co-developing next-generation ultrasound platforms.
  • In April 2025, Exo added real-time Global Longitudinal Strain (GLS) analysis to the Exo Iris(R) (FDA cleared), making it the first handheld to offer on-device GLS for bedside cardiac assessment.
  • In April 2025, Philips rolled out the Elevate AI-enabled platform upgrade for its EPIQ Elite (and related Affiniti platforms), introducing automated image optimization and workflow tools to speed exams and increase diagnostic consistency.
  • In January 2025, Samsung Medison launched the premium OB/GYN system HERA / Z20 in the U.S. (debut at SMFM 2025), featuring AI tools for live quality assistance, automated labeling, and advanced fetal imaging.
  • In January 2025, Hologic finalized a $350 million acquisition of Gynesonics, the developer of the Sonata System (an ultrasound-guided system for uterine fibroid treatment).

Ultrasound Devices Market Segmentation

  • Ultrasound Devices by Product Type Exposure
  • 2D
  • 3D/4D
  • Doppler
  • High-Intensity Focused Ultrasound (HIFU)
  • Ultrasound Devices Device Display Exposure
  • Color Ultrasound
  • B/W Ultrasound
  • Ultrasound Devices Portability Exposure
  • Stationary
  • Portable
  • Ultrasound Devices Application Exposure
  • Gynecology
  • Cardiology
  • Urology
  • Orthopedic
  • Others
  • Ultrasound Devices End-Users Exposure
  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Ambulatory Surgical Centers
  • Others
  • Ultrasound Devices Geography Exposure
  • North America Ultrasound Devices Market
  • United States Ultrasound Devices Market
  • Canada Ultrasound Devices Market
  • Mexico Ultrasound Devices Market
  • Europe Ultrasound Devices Market
  • United Kingdom Ultrasound Devices Market
  • Germany Ultrasound Devices Market
  • France Ultrasound Devices Market
  • Italy Ultrasound Devices Market
  • Spain Ultrasound Devices Market
  • Rest of Europe Ultrasound Devices Market
  • Asia-Pacific Ultrasound Devices Market
  • China Ultrasound Devices Market
  • Japan Ultrasound Devices Market
  • India Ultrasound Devices Market
  • Australia Ultrasound Devices Market
  • South Korea Ultrasound Devices Market
  • Rest of Asia-Pacific Ultrasound Devices Market
  • Rest of the World Ultrasound Devices Market
  • South America Ultrasound Devices Market
  • Middle East Ultrasound Devices Market
  • Africa Ultrasound Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

The integration of artificial intelligence (AI) is a transformative force in the ultrasound devices market, fundamentally reshaping its capabilities and expanding its reach. AI-powered innovations are addressing long-standing challenges by automating time-consuming and operator-dependent tasks, which has a significant impact on workflow efficiency and accuracy. For instance, AI algorithms can automatically acquire and analyze images, freeing up clinicians to focus on patient interaction and reducing examination times.

Furthermore, AI acts as a powerful diagnostic assistant by detecting subtle anomalies and assisting in the classification of lesions, thereby improving diagnostic accuracy and reducing the risk of human error. The most profound impact of AI, however, is the democratization of ultrasound, as AI-guided systems can provide real-time, step-by-step feedback to users, empowering healthcare professionals with limited training to perform diagnostic-quality scans. This is a key driver for the explosive growth of the Point-of-Care Ultrasound (POCUS) market, extending its use to clinics, remote areas, and emergency settings. While challenges such as high costs and the need for large, high-quality datasets for training AI models exist, the future of ultrasound technology is inextricably linked with AI, which will continue to enhance its utility and redefine its role in global healthcare.

U.S. Tariff Impact Analysis on the Ultrasound Devices Market:

The implementation of U.S. tariffs, particularly on medical devices and components from China and the European Union, is creating a significant and multifaceted challenge for the global ultrasound devices market. These tariffs, which can add a considerable percentage to import costs, directly impact manufacturers by either compressing their profit margins or forcing them to pass on the added expenses to healthcare providers and, ultimately, patients. This price increase could potentially slow down the adoption of new ultrasound technology, as hospitals and clinics, especially smaller ones, may find it more difficult to afford capital-intensive equipment.

Furthermore, the tariffs are disrupting established, complex global supply chains, compelling companies to urgently find new suppliers or even consider reshoring manufacturing to avoid the added costs. This can lead to supply shortages, logistical delays, and increased operational expenses, creating market instability. While the tariffs are intended to incentivize domestic production and reduce reliance on foreign suppliers in the long term, they also pose a risk of reducing R&D spending and slowing down innovation, as companies prioritize cost management over new product development. Additionally, the possibility of retaliatory tariffs from affected countries could further harm U.S. medical device exports, adding another layer of complexity to the competitive landscape.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the ultrasound devices market report study

  • Market size analysis for the current ultrasound devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the ultrasound devices market.
  • Various opportunities available for the other competitors in the ultrasound devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current ultrasound devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the ultrasound devices market growth in the future?

Frequently Asked Questions for the Ultrasound Devices Market

1. What is the growth rate of the ultrasound devices market?

  • The ultrasound devices market is estimated to grow at a CAGR of 4.38% during the forecast period from 2025 to 2032.

2. What is the market for ultrasound devices?

  • The ultrasound devices market was valued at USD 9,315.06 million in 2024, and is expected to reach USD 13,054.68 million by 2032.

3. Which region has the highest share in the ultrasound devices market?

  • The North American ultrasound device market is dominating and growing due to its well-established healthcare infrastructure, high adoption of advanced imaging technologies, and strong presence of leading medical device manufacturers. The rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and liver diseases is driving demand for early and accurate diagnostic imaging. The region also benefits from favorable reimbursement policies, higher healthcare expenditure, and growing awareness of preventive healthcare. Continuous product innovations, such as AI-powered ultrasound and portable point-of-care systems, are further fueling adoption across hospitals and outpatient centers. In addition, the aging population and increasing use of ultrasound in women's health, cardiology, and emergency medicine are reinforcing the market's strong growth trajectory.

4. What are the drivers for the ultrasound devices market?

  • The global ultrasound device market is growing due to the rising prevalence of chronic diseases, increasing demand for early and accurate diagnosis, and the expanding use of minimally invasive procedures. Advancements in ultrasound technology, such as 3D/4D imaging, AI integration, and portable handheld systems, are further driving adoption across hospitals, diagnostic centers, and point-of-care settings. Growing awareness of prenatal care and maternal health, coupled with the aging population, has also boosted demand for ultrasound in obstetrics and cardiology. Additionally, ultrasound is cost-effective, safe, and radiation-free compared to other imaging modalities, making it a preferred diagnostic tool. Expanding healthcare infrastructure in emerging markets and favorable government initiatives to enhance access to imaging services are further contributing to market growth.

5. Who are the key players operating in the ultrasound devices market?

  • Some of the key market players operating in the ultrasound devices market include GE HealthCare, Siemens Healthineers, Canon Medical Systems Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Canon Medical Systems Corporation, Samsung Healthcare, FUJIFILM Holdings Corporation, Esaote SpA, Hologic, Inc., Hitachi, Ltd, BPL Medical Technologies, SonoScape Medical Corporation, Butterfly Network, Inc., Carestream Health, Clarius Mobile Health, Trivitron Healthcare, Chison Medical Imaging Co., Ltd., Teratech Corporation, Wuhan Zoncare Bio-medical Electronics Co., Ltd., SuperSonic Imagine, DMS Imaging, and Others.

Table of Contents

1. Ultrasound Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Ultrasound Devices Market Executive Summary

  • 2.1 Market at Glance

3. Ultrasound Devices Market Key Factors Analysis

  • 3.1 Ultrasound Devices Market Drivers
    • 3.1.1 Rising Prevalence of Chronic Diseases
    • 3.1.2 Growing Preference for Non-Invasive and Safer Diagnostics
    • 3.1.3 Advancements in Technology
    • 3.1.4 Rising Demand for Point-of-Care (POCUS)
    • 3.1.5 Expansion into Therapeutic Ultrasound
  • 3.2 Ultrasound Devices Market Restraints and Challenges
    • 3.2.1 High Cost of Advanced Ultrasound Systems
    • 3.2.2 Stringent Regulatory and Reimbursement Policies
    • 3.2.3 Challenges with Portable and Handheld Ultrasound Devices
  • 3.3 Ultrasound Devices Market Opportunity
    • 3.3.1 Integration of artificial intelligence (AI) and machine learning (ML)

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Ultrasound Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Ultrasound Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 2D
    • 7.1.2 3D/4D
    • 7.1.3 Doppler
    • 7.1.4 High-Intensity Focused Ultrasound (HIFU)
  • 7.2 By Device Display
    • 7.2.1 Color Ultrasound
    • 7.2.2 B/W Ultrasound
  • 7.3 By Portability
    • 7.3.1 Stationary
    • 7.3.2 Portable
  • 7.4 By Application
    • 7.4.1 Gynecology
    • 7.4.2 Cardiology
    • 7.4.3 Urology
    • 7.4.4 Orthopedic
    • 7.4.5 Others
  • 7.5 By End-Users
    • 7.5.1 Hospitals
    • 7.5.2 Diagnostic Centers
    • 7.5.3 Clinics
    • 7.5.4 Ambulatory Surgical Centers
    • 7.5.5 Others
  • 7.6 By Geography
    • 7.6.1 North America
      • 7.6.1.1 United States Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.1.2 Canada Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.1.3 Mexico Ultrasound Devices Market Size in USD million (2022-2032)
    • 7.6.2 Europe
      • 7.6.2.1 France Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.2 Germany Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.3 United Kingdom Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.4 Italy Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.5 Spain Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.2.6 Rest of Europe Ultrasound Devices Market Size in USD million (2022-2032)
    • 7.6.3 Asia-Pacific
      • 7.6.3.1 China Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.2 Japan Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.3 India Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.4 Australia Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.5 South Korea Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.3.6 Rest of Asia-Pacific Ultrasound Devices Market Size in USD million (2022-2032)
    • 7.6.4 Rest of the World (RoW)
      • 7.6.4.1 Middle East Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.4.2 Africa Ultrasound Devices Market Size in USD million (2022-2032)
      • 7.6.4.3 South America Ultrasound Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Ultrasound Devices Market Company and Product Profiles

  • 10.1 GE HealthCare
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Siemens Healthineers
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Canon Medical Systems Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 Canon Medical Systems Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Samsung Healthcare
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 FUJIFILM Holdings Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Esaote SpA
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Hologic, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Hitachi, Ltd
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 BPL Medical Technologies
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 SonoScape Medical Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Butterfly Network, Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Carestream Health
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Clarius Mobile Health
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Trivitron Healthcare
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Chison Medical Imaging Co., Ltd.
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Teratech Corporation
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Wuhan Zoncare Bio-medical Electronics Co., Ltd.
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 SuperSonic Imagine
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy
  • 10.21 DMS Imaging
    • 10.21.1 Company Overview
    • 10.21.2 Company Snapshot
    • 10.21.3 Financial Overview
    • 10.21.4 Product Listing
    • 10.21.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Ultrasound Devices Market in Global (2022-2032)
  • Table 2: Ultrasound Devices Market in Global by Product Type (2022-2032)
  • Table 3: Ultrasound Devices Market in Global by Device Display (2022-2032)
  • Table 4: Ultrasound Devices Market in Global by Portability (2022-2032)
  • Table 5: Ultrasound Devices Market in Global by Application (2022-2032)
  • Table 6: Ultrasound Devices Market in Global by End-Users (2022-2032)
  • Table 7: Ultrasound Devices Market in Global by Geography (2022-2032)
  • Table 8: Ultrasound Devices Market in North America (2022-2032)
  • Table 9: Ultrasound Devices Market in the United States (2022-2032)
  • Table 10: Ultrasound Devices Market in Canada (2022-2032)
  • Table 11: Ultrasound Devices Market in Mexico (2022-2032)
  • Table 12: Ultrasound Devices Market in Europe (2022-2032)
  • Table 13: Ultrasound Devices Market in France (2022-2032)
  • Table 14: Ultrasound Devices Market in Germany (2022-2032)
  • Table 15: Ultrasound Devices Market in United Kingdom (2022-2032)
  • Table 16: Ultrasound Devices Market in Italy (2022-2032)
  • Table 17: Ultrasound Devices Market in Spain (2022-2032)
  • Table 18: Ultrasound Devices Market in the Rest of Europe (2022-2032)
  • Table 19: Ultrasound Devices Market in Asia-Pacific (2022-2032)
  • Table 20: Ultrasound Devices Market in China (2022-2032)
  • Table 21: Ultrasound Devices Market in Japan (2022-2032)
  • Table 22: Ultrasound Devices Market in India (2022-2032)
  • Table 23: Ultrasound Devices Market in Australia (2022-2032)
  • Table 24: Ultrasound Devices Market in South Korea (2022-2032)
  • Table 25: Ultrasound Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Ultrasound Devices Market in the Rest of the World (2022-2032)
  • Table 27: Ultrasound Devices Market in the Middle East (2022-2032)
  • Table 28: Ultrasound Devices Market in Africa (2022-2032)
  • Table 29: Ultrasound Devices Market in South America (2022-2032)
  • Table 30: Competitive Landscape
  • Table 31: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Ultrasound Devices Market Drivers
  • Figure 2: Ultrasound Devices Market Restraints
  • Figure 3: Ultrasound Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Ultrasound Devices Market
  • Figure 5: US Tariff Impact on Ultrasound Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Ultrasound Devices Market in Global (2022-2032)
  • Figure 10: Ultrasound Devices Market in Global by Product Type (2022-2032)
  • Figure 11: Ultrasound Devices Market in Global by Device Display (2022-2032)
  • Figure 12: Ultrasound Devices Market in Global by Portability (2022-2032)
  • Figure 13: Ultrasound Devices Market in Global by Application (2022-2032)
  • Figure 14: Ultrasound Devices Market in Global by End-Users (2022-2032)
  • Figure 15: Ultrasound Devices Market in Global by Geography (2022-2032)
  • Figure 16: Ultrasound Devices Market in North America (2022-2032)
  • Figure 17: Ultrasound Devices Market in the United States (2022-2032)
  • Figure 18: Ultrasound Devices Market in Canada (2022-2032)
  • Figure 19: Ultrasound Devices Market in Mexico (2022-2032)
  • Figure 20: Ultrasound Devices Market in Europe (2022-2032)
  • Figure 21: Ultrasound Devices Market in France (2022-2032)
  • Figure 22: Ultrasound Devices Market in Germany (2022-2032)
  • Figure 23: Ultrasound Devices Market in United Kingdom (2022-2032)
  • Figure 24: Ultrasound Devices Market in Italy (2022-2032)
  • Figure 25: Ultrasound Devices Market in Spain (2022-2032)
  • Figure 26: Ultrasound Devices Market in the Rest of Europe (2022-2032)
  • Figure 27: Ultrasound Devices Market in Asia-Pacific (2022-2032)
  • Figure 28: Ultrasound Devices Market in China (2022-2032)
  • Figure 29: Ultrasound Devices Market in Japan (2022-2032)
  • Figure 30: Ultrasound Devices Market in India (2022-2032)
  • Figure 31: Ultrasound Devices Market in Australia (2022-2032)
  • Figure 32: Ultrasound Devices Market in South Korea (2022-2032)
  • Figure 33: Ultrasound Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 34: Ultrasound Devices Market in the Rest of the World (2022-2032)
  • Figure 35: Ultrasound Devices Market in the Middle East (2022-2032)
  • Figure 36: Ultrasound Devices Market in Africa (2022-2032)
  • Figure 37: Ultrasound Devices Market in South America (2022-2032)
  • Figure 38: Competitive Landscape
  • Figure 39: Startup Funding & Investment Trends